World Wires · story 31243 · unverified · 1 source(s)

Retension Pharmaceuticals Announces Pricing of Initial Public Offering

FALLS CHURCH, Va., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Retension Pharmaceuticals, Inc. (Nasdaq: RTSN) (“Retension” or the “Company”), a clinical-stage biopha

Open in the desk

Coverage

• Retension Pharmaceuticals Announces Pricing of Initial Public Offering GlobeNewswire: public companies · tier D · clear net · 2026-10-09 01:35 UTC

What this site indexes